Who's Blogging
- Marty Resnick
- Sally Witzky
- Mark Mcdonald
- John Wheeler
- Daniel Sanchezreina
- Debbie Wilson
- Bill Ray
- David Furlonger
- Christophe Uzureau
- Mark Atwood
- Clare Dietz
- Camden Jones
- Jack Mackinnon
- Andrew White
- Chris Ross
- Don Scheibenreif
- Steve Rietberg
- Avivah Litan
- Mike Wonham
- Dave Egloff
- Deacon Wan
- Augie Ray
- Hanns Koehler
- Marc Brown
- Noah Elkin
- Benjamin Bloom
- Jitendra Subramanyam
- Claire Tassin
- Lydia Leong
- Hank Barnes
- Andrew Marder
- Rene Buest
- Laurel Erickson
- Olive Huang
- Christian Ruzich
- Derek Stubbs
- Merv Adrian
- Rick Lafond
- Vivek Swaminathan
- Anna Maria
- Donald Feinberg
- Adam Ronthal
- Tim Barlow
- Craig Roth
- Stephen White
- Andrew Lerner
- Tad Travis
- Jane Anne
- Lawrence Pingree
- Frances Russell
2 x Life Science Hype Cycles
by Michael Shanler | July 29, 2017
While the spring rains drenched the northeastern U.S. and parts of Europe, Jeff, Steve, and I were hard at work authoring, arranging, writing, reviewing, re-reviewing, re-re-reviewing our content. After countless...
A CIO’s 24 Hours of Le Mans
by Michael Shanler | June 28, 2017
CIOs are competing in an endurance race. Winning requires carefully orchestrated activities that rely on technology, team work, precision driving, and a bit of luck. As in racing, the victorious...
Hype Cycle for Life Science R&D
by Michael Shanler | July 25, 2016
This year, we unveiled a brand new hype cycle, one that is 100% Life Science R&D-focused.
“… the moon does not present the same face every day. It waxes, or grows larger, until...
Mutate the DNA of Pharma Externalization
by Michael Shanler | May 12, 2016
Here’s a prediction. Life Science CxOs that continue to oversimplify “externalized innovation” strategies are in for a career-ending surprise in a few years. For details, check this out: Industry...
Hey Pharma, Did you listen to Elon?
by Michael Shanler | April 3, 2016
The Tesla Model 3 was unveiled a few days ago. There are already over 250,000 people plopping down $1,000 deposits to reserve a product they haven’t physically seen or touched...
“Accelerating R&D” Key Initiatives for Life Science Manufacturers 2016
by Michael Shanler | January 27, 2016
Before each calendar year begins, we put a lot of effort into outlining areas of research and how these areas align with strategic key initiatives (KIs). The life science-related KIs...
Cool Vendors in Life Science
by Michael Shanler | April 24, 2015
Last week, Stephen Davies and I published the Cool Vendors report for Life Science. The vendors mentioned are all relative new comers (either by incorporation date, or they have recently...
Gartner 2015 Life Sciences Agenda Has Published
by Michael Shanler | February 15, 2015
Last year, having spent an exceptional amount of quality time with clients, at conferences, and doing research, caused me to reflect on my teenage conversations with my grandparents. Older, wiser...
Wearable Devices? Ha! What’s Your Appetite for Ingestibles?
by Michael Shanler | January 15, 2015
We’ve seen an explosion in wearable devices. As for impacts of IoT and wearables in life science? We are in the early days. Today, some clinical trial designers are leveraging...
Life Science Track at Orlando ITxpo 2014 Symposium
by Michael Shanler | September 12, 2014
This year, Gartner has organized a specific Life Science IT track on "Industry Sunday." This is a great opportunity for IT and CxO business leaders to have dialog about the...
